These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 8039197

  • 1. [Evaluation of the chronic antihypertensive effect of nitrendipine using ambulatory monitoring].
    Rossi L, Tomei R, Carbonieri E, Franceschini L, Zardini P.
    Cardiologia; 1994 Mar; 39(3):187-91. PubMed ID: 8039197
    [Abstract] [Full Text] [Related]

  • 2. [Nitrendipine: evaluation of the duration of the antihypertensive effect at different doses using the conventional method and ambulatory monitoring of arterial pressure].
    Giarrizzo C, Germanò G, Leonetti-Luparini R, Ferri C, Caparra A, Coia F, Santucci A.
    Cardiologia; 1990 Sep; 35(9):751-7. PubMed ID: 2091826
    [Abstract] [Full Text] [Related]

  • 3. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
    Mengden T, Schubert M, Jeck T, Edmonds D, Vetter W.
    J Hypertens Suppl; 1990 Sep; 8(4):S91-4. PubMed ID: 1979615
    [Abstract] [Full Text] [Related]

  • 4. [24-hour antihypertensive efficacy of nitrendipine].
    Spritzer N, Medeiros CM, Spritzer TS, Medeiros NK.
    Arq Bras Cardiol; 1990 Jul; 55(1):71-4. PubMed ID: 2073165
    [Abstract] [Full Text] [Related]

  • 5. The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients.
    el-Beheiry H, Ruedy N, Wall RA, Murphy M, Wright JM.
    Can J Cardiol; 1993 Jul; 9(1):41-6. PubMed ID: 8439828
    [Abstract] [Full Text] [Related]

  • 6. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 7. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K, Zhang B, Okamoto T, Takeda Y, Liu K, Jimi S, Arakawa K.
    J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive monotherapy with nitrendipine in general practice.
    Braun H, Weber F.
    J Cardiovasc Pharmacol; 1991 Apr; 18 Suppl 1():S59-62. PubMed ID: 1723458
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the antihypertensive effect and tolerability of a new delayed-action calcium channel blocker: nitrendipine, prescribed as a single daily dose of 20 mg].
    Herpin D, Amiel A, Boutaud P, Ciber MA, Demange J.
    Ann Cardiol Angeiol (Paris); 1986 Nov; 35(9):561-6. PubMed ID: 3813462
    [Abstract] [Full Text] [Related]

  • 10. Nitrendipine in treatment of hypertension.
    Jaroonvesama N.
    J Med Assoc Thai; 1991 May; 74(5):278-82. PubMed ID: 1783876
    [Abstract] [Full Text] [Related]

  • 11. An open, parallel, comparative evaluation of amlodipine and nitrendipine in the monotherapeutic treatment of mild and moderate essential hypertension.
    Englert R, Beressem P, von Manteuffel E, Stafunsky S, Kramar M.
    J Cardiovasc Pharmacol; 1991 May; 17 Suppl 1():S22-4. PubMed ID: 16296702
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of once daily nitrendipine in essential hypertension--a study using ambulatory blood pressure monitoring.
    Lazarus JH, Littley MD, Phillips DI.
    J Hum Hypertens; 1988 Oct; 2(3):191-4. PubMed ID: 3236323
    [Abstract] [Full Text] [Related]

  • 13. Nitrendipine once daily compared with nicardipine in the treatment of mild to moderate hypertension.
    Palermo R, Conti V, Agostinelli MC, Ganzetti S, Racco F, Melappioni A, Pratillo G, Moretti S.
    Clin Ther; 1990 Oct; 12(2):149-56. PubMed ID: 2354484
    [Abstract] [Full Text] [Related]

  • 14. Parallel comparative trial of amlodipine and nitrendipine monotherapy in patients with essential hypertension.
    Wang X, Gong L, Guo J, Wang X, Liu Y, Ye X, Zhang G, Yang P.
    J Hypertens Suppl; 1998 Sep; 16(4):S43-7. PubMed ID: 9817192
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
    Lohmann FW, Welzel D, Burger KJ.
    Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
    [Abstract] [Full Text] [Related]

  • 17. Effect of nitrendipine in mild or moderate essential hypertensive subjects with type II diabetes.
    Papalia D, Casale P.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 1():S98-100. PubMed ID: 1723469
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nitrendipine efficacy and safety in patients with mild and moderate essential hypertension.
    Di Salvo MM, Finocchiaro PM, Bonaccorso M, Attanasio L.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 1():S45-7. PubMed ID: 1723454
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.